207 related articles for article (PubMed ID: 29238632)
21. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.
Sakhdari A; Tang G; Ginsberg LE; Hirsch-Ginsberg CF; Bueso-Ramos CE; Medeiros LJ; Miranda RN
Case Rep Pathol; 2019; 2019():4915086. PubMed ID: 30941227
[TBL] [Abstract][Full Text] [Related]
22. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
23. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
[TBL] [Abstract][Full Text] [Related]
24. De-novo CD5 + B- prolymphocytic leukemia (PLL) presenting at younger age with favourable outcome.
Kar R; Kumar R; Tyagi S
Turk J Haematol; 2008 Sep; 25(3):149-51. PubMed ID: 27264708
[TBL] [Abstract][Full Text] [Related]
25. A Comprehensive Update on Molecular and Cytogenetic Abnormalities in T-cell Prolymphocytic Leukemia (T-pll).
Delgado P; Starshak P; Rao N; Tirado CA
J Assoc Genet Technol; 2012; 38(4):193-8. PubMed ID: 23183331
[TBL] [Abstract][Full Text] [Related]
26. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
27. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract][Full Text] [Related]
28. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
Jain P; Aoki E; Keating M; Wierda WG; O'Brien S; Gonzalez GN; Ferrajoli A; Jain N; Thompson PA; Jabbour E; Kanagal-Shamanna R; Pierce S; Alousi A; Hosing C; Khouri I; Estrov Z; Cortes J; Kantarjian H; Ravandi F; Kadia TM
Ann Oncol; 2017 Jul; 28(7):1554-1559. PubMed ID: 28379307
[TBL] [Abstract][Full Text] [Related]
29. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Cao TM; Coutre SE
Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
[TBL] [Abstract][Full Text] [Related]
30. PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.
Nachat A; Turoff-Ortmeyer S; Liu C; Mcculloch M
Perm J; 2016; 20(2):74-80. PubMed ID: 27168399
[TBL] [Abstract][Full Text] [Related]
31. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
[TBL] [Abstract][Full Text] [Related]
32. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
33. Advances in the understanding and management of T-cell prolymphocytic leukemia.
Laribi K; Lemaire P; Sandrini J; Baugier de Materre A
Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669
[TBL] [Abstract][Full Text] [Related]
34. Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia.
Varadarajan I; Ballen K
Front Oncol; 2022; 12():781479. PubMed ID: 35223471
[TBL] [Abstract][Full Text] [Related]
35. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
[TBL] [Abstract][Full Text] [Related]
36. T gamma lymphocytosis and T cell chronic leukemias.
Berliner N
Hematol Oncol Clin North Am; 1990 Apr; 4(2):473-87. PubMed ID: 2182603
[TBL] [Abstract][Full Text] [Related]
37. A Complex Karyotype in a 68-Year-Old Patient With T-PLL.
Yang GE; Bottomley S; King J; Koss W; Lin Y; Yeh W; Tirado CA
J Assoc Genet Technol; 2021; 47(1):16-23. PubMed ID: 33684910
[TBL] [Abstract][Full Text] [Related]
38. A T-cell prolymphocytic leukemia case with central nervous system involvement.
Malkan UY; Gunes G; Yayar O; Demiroglu H; Yesilirmak A; Uner A
Int J Clin Exp Med; 2015; 8(8):14207-9. PubMed ID: 26550397
[TBL] [Abstract][Full Text] [Related]
39. T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India.
Babu Mc S; Anand A; Lakshmaiah KC; Babu K G; Lokanatha D; Jacob LA; Madhumathi DS; Lokesh KN; Rudresha AH; Rajeev LK; Patidar R
Int J Hematol Oncol Stem Cell Res; 2018 Apr; 12(2):132-135. PubMed ID: 30233775
[No Abstract] [Full Text] [Related]
40. T-cell prolymphocytic leukemia: a report of two cases with review of literature.
Naseem S; Gupta R; Kashyap R; Nityanand S
Indian J Hematol Blood Transfus; 2008 Dec; 24(4):178-81. PubMed ID: 23100959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
